Canada - engelsk - Health Canada

sandoz canada incorporated - dexamethasone phosphate (dexamethasone sodium phosphate) - solution - 4mg - dexamethasone phosphate (dexamethasone sodium phosphate) 4mg - adrenals

Canada - engelsk - Health Canada

sandoz canada incorporated - dexamethasone phosphate (dexamethasone sodium phosphate) - solution - 10mg - dexamethasone phosphate (dexamethasone sodium phosphate) 10mg - adrenals

Malta - engelsk - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - dexamethasone sodium, phosphate - solution for injection - dexamethasone sodium phosphate 6 mg - corticosteroids for systemic use

Irland - engelsk - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - dexamethasone sodium phosphate - solution for injection/infusion - 4 milligram(s)/millilitre - glucocorticoids; dexamethasone

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - dexamethasone phenylpropionate; dexamethasone sodium phosphate - parenteral liquid/solution/suspension - dexamethasone phenylpropionate steroid-glucocorticoid active 2.0 mg/ml; dexamethasone sodium phosphate steroid-glucocorticoid active 1.0 mg/ml - endocrine system - cat | cattle | dog | goat | horse | pigs | sheep | beef | billy | bitch | boar | bos indicus | bos taurus | bovine | buck | buff - anti-inflammatory agent | antipyretic | bone soreness | bruising | bursitis | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle soreness | osteoarthritis | platelet activity | rheumatism | sprains | strains | tendon sprains | traumatic swelling

Canada - engelsk - Health Canada

omega laboratories limited - dexamethasone phosphate (dexamethasone sodium phosphate) - solution - 10mg - dexamethasone phosphate (dexamethasone sodium phosphate) 10mg - adrenals

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dexamethasone sodium phosphate 4.37 mg/ml equivalent to 4 mg dexamethasone phosphate - solution for injection - 4 mg/ml - active: dexamethasone sodium phosphate 4.37 mg/ml equivalent to 4 mg dexamethasone phosphate excipient: disodium edetate hydrochloric acid sodium citrate sodium hydroxide sodium sulfite water for injection - dexamethasone has predominantly glucocorticoid activity and therefore is not a complete replacement therapy in cases of adrenocortical insufficiency. dexamethasone should be supplemented with salt and/or a mineralocorticoid, such as deoxycorticosterone. when so supplemented, dexamethasone is indicated in: · acute adrenocortical insufficiency - addison's disease, bilateral adrenalectomy; · relative adrenocortical insufficiency - prolonged administration of adrenocortical steroids can produce dormancy of the adrenal cortex. the reduced secretory capacity gives rise to a state of relative adrenocortical insufficiency which persists for a varying length of time after therapy is discontinued. hould a patient be subjected to sudden stress during this period of reduced secretion (for up to two years after therapy has ceased) the steroid output may not be adequate. steroid therapy should therefore be reinstituted to help cope with stress such as that associated with surgery, trauma, burns, or severe infections where specific antibiotic therapy is available; · primary and secondary adrenocortical insufficiency.

USA - engelsk - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - dexamethasone phosphate 4 mg in 1 ml

USA - engelsk - NLM (National Library of Medicine)

remedyrepack inc. - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - dexamethasone phosphate 4 mg in 1 ml

USA - engelsk - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - prednisolone sodium phosphate (unii: iv021nxa9j) (prednisolone - unii:9phq9y1olm) - prednisolone 21-phosphate 10 mg - prednisolone sodium phosphate orally disintegrating tablets are indicated in the treatment of the following diseases or conditions: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adult and pediatric populations with: during acute episodes in: for the treatment of: to induce a diuresis or remission of proteinuria in nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus as adjunctive therapy for short term administration (to tide the patient over an acute episode or exacerbation) in: during an exacerbation or as maintenance therapy in selected cases of: prednisolone sodium phosphate orally disintegrating tablets are contraindicated in patients who are hypersensitive to corticosteroids such as prednisolone or any components of this product. rare instances of anaphylactoid reactions have occurred in patients receiving corticosteroid therapy. based on findings from human and animal studies, corticosteroids